By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Eleven Biotherapeutics 



Cambridge  Massachusetts    U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
Eleven Biotherapeutics (EBIO) To Present In Upcoming Investor Conferences In February 1/29/2015 11:17:29 AM
Eleven Biotherapeutics (EBIO) Appoints Barry Gertz, MD, PhD, And Jay S. Duker, MD, To Board Of Directors 1/22/2015 11:04:48 AM
Eleven Biotherapeutics (EBIO) To Present At Oppenheimer 25th Annual Healthcare Conference 11/26/2014 8:31:50 AM
Eleven Biotherapeutics (EBIO) Scores Additional $20 Million Financing 11/25/2014 6:25:06 AM
Eleven Biotherapeutics (EBIO) Reports Third Quarter 2014 Financial Results 11/13/2014 10:47:32 AM
Eleven Biotherapeutics (EBIO) To Report Third Quarter 2014 Financial Results On November 13, 2014 11/4/2014 10:04:23 AM
Eleven Biotherapeutics (EBIO) Completes Enrollment In Pivotal Phase 3 Study Of EBI-005 In Patients With Dry Eye Disease 11/3/2014 10:36:17 AM
Eleven Biotherapeutics (EBIO) Appoints Wendy L. Dixon, PhD To Board Of Directors 10/23/2014 11:43:38 AM
Eleven Biotherapeutics (EBIO) Granted U.S. Composition-of-Matter Patent For EBI-005 10/7/2014 8:25:31 AM
Eleven Biotherapeutics (EBIO)' EBI-005 Misses Primary Endpoint In Phase 2 Trial 10/2/2014 9:56:26 AM
12345
//-->